Report of The Urgent Need Initiative
The Urgent Need Initiative was established to address concerns surrounding the relentless rise in antibiotic resistance, occurring at a time when pharmaceutical companies are disinvesting in the discovery and
development of antibacterial agents. The report examined the three major components required to bring antibacterial agents to market – research, regulation and economics – and records the discussions held at three expert evidence sessions.
The report does not seek simply to reiterate problems that have been rehearsed, recorded and reported so many times before, but identifies practical solutions that can be developed, applied and implemented, using existing systems for
research, regulation and pricing.
A copy of the report can be accessed here:
Report of the British Society for Antimicrobial Chemotherapy Initiative